Pharmacokinetic disposition of subcutaneously administered enrofloxacin in goats
- PMID: 12416871
- DOI: 10.1023/a:1020295632767
Pharmacokinetic disposition of subcutaneously administered enrofloxacin in goats
Abstract
The pharmacokinetic disposition of enrofloxacin was studied in goats after subcutaneous (s.c.) administration at a single dose of 7.5 mg/kg body weight. Blood samples were drawn from a jugular vein into heparinized tubes at predetermined time intervals after administration of the drug and the plasma was separated by centrifugation. The concentrations of enrofloxacin in the plasma were determined by a microbiological assay using Escherichia coli as the test organism. The plasma concentration-time data were analysed by non-compartmental methods. Enrofloxacin was rapidly absorbed, an appreciable concentration of the drug (0.30 +/- 0.13 microg/ml) being present in the plasma by 5 min after s.c. administration. The maximum plasma concentration of enrofloxacin and the time to reach that maximum were 2.91 +/- 0.39 microg/ml and 2.9 +/- 0.51 h. respectively. A detectable concentration of enrofloxacin persisted in the plasma for 12 h. The elimination half-life and mean residence time of enrofloxacin were 2.84 +/- 0.57 and 5.74 +/- 0.28 h, respectively. It is suggested that enrofloxacin given subcutaneously may be useful in the treatment of susceptible bacterial infections in goats.
Similar articles
-
Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin in goats given enrofloxacin alone and in combination with probenecid.Vet J. 2002 Jan;163(1):85-93. doi: 10.1053/tvjl.2001.0594. Vet J. 2002. PMID: 11749141
-
Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intramuscular administration of enrofloxacin in goats.Vet Res Commun. 2001 Apr;25(3):197-204. doi: 10.1023/a:1006481625615. Vet Res Commun. 2001. PMID: 11334149
-
Disposition kinetics of enrofloxacin (Baytril 5%) in sheep and goats following intravenous and intramuscular injection using a microbiological assay.Res Vet Sci. 2002 Oct;73(2):125-9. doi: 10.1016/s0034-5288(02)00020-6. Res Vet Sci. 2002. PMID: 12204629 Clinical Trial.
-
Effects of endotoxin-induced fever and probenecid on disposition of enrofloxacin and its metabolite ciprofloxacin after intravascular administration of enrofloxacin in goats.J Vet Pharmacol Ther. 2000 Dec;23(6):365-72. doi: 10.1046/j.1365-2885.2000.00295.x. J Vet Pharmacol Ther. 2000. PMID: 11168914
-
Disposition of single-dose oral enrofloxacin in the horse.J Vet Pharmacol Ther. 1996 Aug;19(4):316-9. doi: 10.1111/j.1365-2885.1996.tb00057.x. J Vet Pharmacol Ther. 1996. PMID: 8866463 Review. No abstract available.
Cited by
-
Pharmacokinetic behaviour of enrofloxacin and its metabolite ciprofloxacin after subcutaneous administration in cattle.Vet Res Commun. 2008 Apr;32(4):275-9. doi: 10.1007/s11259-008-9037-y. Epub 2008 Feb 5. Vet Res Commun. 2008. PMID: 18247149
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources